Affimed NV (NASDAQ:AFMD) Q2 2022 Earnings Conference Call August 11, 2022 8:30 AM ET Company Participants Alexander Fudukidis - Head, IR Adi Hoess - CEO Angus Smith - CFO Andreas Harstrick - Chief Medical Officer Conference Call Participants Daina Graybosch - SVB Securities Maurice Raycroft - Jefferies Li Watsek - Cantor Fitzgerald & Co. Zhiqiang Shu - Berenberg Yale Jen - Laidlaw & Company Bijan Mekoba - Stifel, Nicolaus & Company Operator Good day, everyone, and welcome to the Affimed Second Quarter 2022 ...

Affimed N.V. (NASDAQ:AFMD) Q1 2022 Results Conference Call June 1, 2022 8:30 AM ET Company Participants Alex Fudukidis - Head of Investor Relations Adi Hoess - Chief Executive Officer Andreas Harstrick - Chief Medical Officer Arndt Schottelius - Chief Scientific Officer Wolfgang Fischer - Chief Operating Officer Angus Smith - Chief Financial Officer Conference Call Participants Daina Graybosch - SVB Securities Kripa Devarakonda - Truist Securities Maury Raycroft - Jefferies Li Watsek - Cantor Brad Canino - ...

Affimed N.V. (NASDAQ:AFMD) Q4 2021 Earnings Conference Call March 31, 2022 8:30 AM ET Company Participants Adi Hoess – Chief Executive Officer Angus Smith – Chief Financial Officer Alex Fudukidis – Head of Investor Relations Andreas Harstrick – Chief Medical Officer Arndt Schottelius – Chief Scientific Officer Denise Miller – Chief Business Officer Conference Call Participants Daina Graybosch – SVB Leerink Kripa Devarakonda – Truist Securities Maury Raycroft – Jefferies Brad Kimmino – Stifel Li Watsek – Can ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021. OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTI ...

Affimed N.V. (NASDAQ:AFMD) Q3 2021 Earnings Conference Call November 9, 2021 8:30 AM ET Company Participants Adi Hoess – Chief Executive Officer Alex Fudukidis – Head of Investor Relations Andreas Harstrick – Chief Medical Officer Arndt Schottelius – Chief Scientific Officer Wolfgang Fischer – Chief Operating Officer Denise Miller – Chief Business Officer Angus Smith – Chief Financial Officer Conference Call Participants Daina Graybosch – SVB Leerink Maury Raycroft – Jefferies Unidentified Analyst – Tourist ...